Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Panbela Therapeutics Inc. buy Maxim Group

Panbela Therapeutics Inc.
Start price
€6.36
20.03.23 / 50%
Target price
-
20.03.24
Performance (%)
-96.67%
End price
-
21.03.24
Summary
This prediction is currently being closed. The BUY prediction by Maxim_Group for Panbela Therapeutics Inc. is performing very badly with a performance of -96.67%. Maxim_Group has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Panbela Therapeutics Inc. - - - -
iShares Core DAX® -1.586% 5.028% 6.332% 64.061%
iShares Nasdaq 100 -4.148% -0.125% 25.735% 86.918%
iShares Nikkei 225® -6.302% 0.528% 41.384% 77.872%
iShares S&P 500 -3.225% 0.470% 20.449% 68.192%

Comments by Maxim_Group for this prediction

In the thread Panbela Therapeutics Inc. diskutieren

Panbela Therapeutics, Inc. (NASDAQ: PBLA) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for PBLA provided by MarketBeat

Maxim Group 
0
Report Share
20.03.23 Buy -96.67%
In the thread Trading Panbela Therapeutics Inc.
Prediction Buy
Perf. (%) -96.67%
Target price
Change
Ends at 20.03.24

Die von Maxim_Group gewählte maximale Laufzeit wurde überschritten

Maxim Group 
0
Report Share
21.03.24